• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    88.11 Down 0.04(0.05%) May 29, 4:00PM EDT
    |After Hours : 88.11 0.00 (0.00%) May 29, 4:32PM EDT
    Add to Portfolio
    Prev Close:88.15
    Open:88.15
    Bid:60.03 x 100
    Ask:95.41 x 500
    1y Target Est:103.00
    Beta:0.83
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:86.56 - 88.73
    52wk Range:41.99 - 90.48
    Volume:234,813
    Avg Vol (3m):427,370
    Market Cap:1.73B
    P/E (ttm):175.17
    EPS (ttm):0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 0.05%1.73B
    LLYUp 3.26%83.56B
    MRKUp 1.99%172.03B
    RHHBYUp 2.83%N/A

    Key Statistics

    Forward P/E (1 yr):28.51
    P/S (ttm):27.44
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.02
    Quarterly EPS Est (Jun-15) :0.40
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):0.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback